Expression and role of myeloid-related protein-14 in clinical and experimental sepsis

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 11, 2009, Pages 1098-1106

  Van Zoelen, Marieke A D ^a   Vogl, Thomas ^b   Foell, Dirk ^b   Van Veen, Suzanne Q ^c   Van Till, Jan W O ^a   Florquin, Sandrine ^a   Tanck, Michael W ^a   Wittebole, Xavier ^d   Laterre, Pierre François ^d   Boermeester, Marja A ^a   Roth, Johannes ^b   Van Poll, Tom Der ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c CENTRAL LABORATORY   (Netherlands)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Calgranulin; Myeloid related protein 8 14; S100A8 S100A9; Sepsis; Toll like receptor 4

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID RELATED PPROTEIN 14; MYELOID RELATED PROTEIN 8; PROTEIN S 100; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENDOTOXEMIA; ESCHERICHIA COLI INFECTION; EXPERIMENTAL INFECTION; FEMALE; HEPATITIS; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; KUPFFER CELL; LIVER INJURY; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NORMAL HUMAN; PERITONEUM LAVAGE; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SEPSIS; WILD TYPE;

AGED; ANIMALS; CALGRANULIN A; CALGRANULIN B; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, INBRED C57BL; PERITONITIS; SEPSIS;

EID: 72749096954     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200810-1552OC     Document Type: Article

References (51)

1. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-214.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310. (Pubitemid 32641789)
3. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
4. Bosscha K, Reijnders K, Hulstaert PF, Algra A, van der Werken C. Prognostic scoring systems to predict outcome in peritonitis and intraabdominal sepsis. Br J Surg 1997;84:1532-1534. (Pubitemid 27485524)
5. McClean KL, Sheehan GJ, Harding GK. Intraabdominal infection: a review. Clin Infect Dis 1994;19:100-116.
6. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
7. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008;8:32-43.
8. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81:1-5.
9. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003;24:155-158. (Pubitemid 36412096)
10. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007;81:28-37. (Pubitemid 46021248)
11. Vogl T, Roth J, Sorg C, Hillenkamp F, Strupat K. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. J Am Soc Mass Spectrom 1999;10:1124-1130. (Pubitemid 34498669)
12. Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, Foell D, Gerke V, Manitz MP, Nacken W, et al. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004;104:4260-4268. (Pubitemid 39620181)
13. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13:1042-1049. (Pubitemid 47517513)
14. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004;50:3762-3771. (Pubitemid 39643922)
15. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 2003;23:1034-1043. (Pubitemid 36133519)
16. Renckens R, Roelofs JJ, Florquin S, de Vos AF, Pater JM, Lijnen HR, Carmeliet P, van't Veer C, van der Poll T. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J Immunol 2006;177:1189-1196. (Pubitemid 44036623)
17. Renckens R, Roelofs JJ, Florquin S, de Vos AF, Lijnen HR, van't Veer C, van der Poll T. Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J Immunol 2006;176:3735-3741.
18. Renckens R, Roelofs JJ, ter Horst SA, van't Veer C, Havik SR, Florquin S, Wagenaar GT, Meijers JC, van der Poll T. Absence of thrombinactivatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice. J Immunol 2005;175:6764-6771.
19. van Zoelen MAD, Vogl T, Florquin S, Roth J, van der Poll T. Absence of MRP14 protects against sepsis-induced liver injury in mice. Abstract and oral presentation presented at the 3rd International Damage Associated Molecular Pattern Molecules (DAMPs) and Alarmins Symposium. August 30-September 2, 2008, Pittsburgh, PA.
20. Abstract in J Leukoc Biol 2008;84:A30-A31.
21. van Zoelen MAD, Vogl T, Florquin S, Roth J, van der Poll T. Absence of MRP14 protects against sepsis-induced liver injury in mice [Abstract No. 22]. Abstract and oral presentation presented at the Annual Meeting of the Netherlands Association of Internal Medicine, April 23-24, 2008; Maastricht, The Netherlands.
22. van Zoelen MA, Laterre PF, van Veen SQ, van Till JW, Wittebole X, Bresser P, Tanck MW, Dugernier T, Ishizaka A, Boermeester MA, et al. Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med 2007;35:2799-2804. (Pubitemid 350175778)
23. Roth J, Burwinkel F, van den BC, Goebeler M, Vollmer E, Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993;82:1875-1883. (Pubitemid 23278779)
24. Viemann D, Strey A, Janning A, Jurk K, Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005;105:2955-2962. (Pubitemid 40446292)
25. Yamamoto T, Naito M, Moriyama H, Umezu H, Matsuo H, Kiwada H, Arakawa M. Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate. Am J Pathol 1996;149:1271-1286. (Pubitemid 26337245)
26. Dory D, Echchannaoui H, Letiembre M, Ferracin F, Pieters J, Adachi Y, Akashi S, Zimmerli W, Landmann R. Generation and functional characterization of a clonal murine periportal Kupffer cell line from H-2Kb-tsA58 mice. J Leukoc Biol 2003;74:49-59. (Pubitemid 38040436)
27. Newton RA, Hogg N. The human S100 protein MRP-14 is a novel activator of the b2 integrin Mac-1 on neutrophils. J Immunol 1998;160:1427-1435. (Pubitemid 28093444)
28. Srikrishna G, Panneerselvam K, Westphal V, Abraham V, Varki A, Freeze HH. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 2001;166:4678-4688. (Pubitemid 32233755)
29. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 2003;171:2602-2609. (Pubitemid 37025572)
30. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003;170:3233-3242. (Pubitemid 36302201)
31. Knapp S, de Vos AF, Florquin S, Golenbock DT, van der Poll T. Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect Immun 2003;71:6747-6753. (Pubitemid 37475302)
32. Knapp S, Matt U, Leitinger N, van der Poll T. Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J Immunol 2007;178:993-1001. (Pubitemid 46095173)
33. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3:169-176. (Pubitemid 37328694)
34. van Westerloo DJ, Weijer S, Bruno MJ, de Vos AF, van't Veer C, van der Poll T. Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis. Crit Care Med 2005;33:1036-1043.
35. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, Harms E, Sorg C, Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000;43:628-637. (Pubitemid 30394955)
36. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496-9502. (Pubitemid 27154966)
37. Holzheimer RG, Muhrer KH, L'Allemand N, Schmidt T, Henneking K. Intraabdominal infections: classification, mortality, scoring and pathophysiology. Infection 1991;19:447-452.
38. Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 1991;266:7706-7713. (Pubitemid 21906422)
39. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987;330:80-82. (Pubitemid 17152420)
40. Zwadlo G, Bruggen J, Gerhards G, Schlegel R, Sorg C. Two calciumbinding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 1988;72:510-515. (Pubitemid 18159941)
41. Foell D, Hernandez-Rodriguez J, Sanchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004;204:311-316. (Pubitemid 39430091)
42. Raquil MA, Anceriz N, Rouleau P, Tessier PA. Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia. J Immunol 2008;180:3366-3374.
43. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004;344:37-51. (Pubitemid 38626135)
44. Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with in- flammatory rheumatic diseases. J Rheumatol 1994;21:733-738. (Pubitemid 24126774)
45. Roth J, Teigelkamp S, Wilke M, Grun L, Tummler B, Sorg C. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992;186:304-314.
46. Lagasse E, Weissman IL. Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. Blood 1992;79:1907-1915.
47. Hirono K, Foell D, Xing Y, Miyagawa-Tomita S, Ye F, Ahlmann M, Vogl T, Futatani T, Rui C, Yu X, et al. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease. J Am Coll Cardiol 2006;48:1257-1264. (Pubitemid 44345126)
48. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ, Hogg N. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 2003;23:2564-2576. (Pubitemid 36351035)
49. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336:763-765. (Pubitemid 20312185)
50. Arai K, Yamada T, Nozawa R. Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. Med Oncol 2000;17:183-188. (Pubitemid 30655739)
51. Yang TH, Tzeng S, Cheng I, Burnett MG, Yoshizawa Y, Fukuyama K, Lee SC, Epstein WL. Identification of the mouse calcium-binding proteins, MRP 8 and MRP 14, in Schistosoma mansoni-induced granulomas: biochemical and functional characterization. J Leukoc Biol 1997;61:258-266. (Pubitemid 27149904)